期刊文献+

树突状细胞抗肿瘤免疫治疗进展 被引量:1

下载PDF
导出
出处 《实用肿瘤学杂志》 CAS 2005年第3期233-237,共5页 Practical Oncology Journal
  • 相关文献

参考文献21

  • 1David MH, Madhav DS, Jeffrey RL, et al. Potential regulatory function of human dendritic cells expressing indoleamine 2, 3-dioxygenase [J]. Science, 2002,297:1867 被引量:1
  • 2Fong L, Engleman EG. Dendritic cells in cancer immunotherapy[J]. Annu Rev Immunol, 2000;18:245~273 被引量:1
  • 3Steinman RM, Dhodapkar M. Active immunization against cancer with dendritic cells: the near future [J].Int J Cancer, 2001;94:459~473 被引量:1
  • 4Mary FL, Barbara JM. Dendritic Cells: Immune Regulators in Hea1th and Disease [J].Phys iological Reviews, 2002;82:97~130 被引量:1
  • 5Tjoa BA, Elgamal AA, Murphy GP. Vaccine therapy for prostate cancer [J]. Urol Clin North Am, 1999;26(2):365~374 被引量:1
  • 6Davis I. Genetransfer into dendritic cells [J]. Cancer Forum, 1999;23(2):107~109 被引量:1
  • 7Bail L, Feuerer M, Beclhove P, et al. Generation of DCs from human bone marrow mononuclear cell: Adavantages for clinical application in comparison to peripheral blood monocyte DCs [J]. Int J Oncol, 2002,20(2):247~253 被引量:1
  • 8Massimo DN, Roberto ML. Dendritic cells: specialized antigen presenting cells [J]. Haematologica, 2000;85(2):202~207 被引量:1
  • 9Hsu FJ, Benike C, Fagnoni F, et al. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells [J]. Nat Med, 1996;2:52~58 被引量:1
  • 10LeBon, A. et al. Cross-priming of CD 8+ T cells stimulated by virus-induced Type I Interferon [J].. Nat. Immunol, 2003;4:1009~1015 被引量:1

同被引文献14

  • 1杨莉,成丽,魏于全.脂质体在肿瘤靶向治疗中的应用[J].华西医学,2005,20(2):387-388. 被引量:7
  • 2Zhang Y, Wakita D, Chamoto K, et al. Thl cell adjuvanttherapy combined with tumor vaccination: a novel strategyfor promoting CTL responses while avoiding the accumula-tion of Tregs[ J] . Int Immunol,2007 ,19(2) : 151 - 161. 被引量:1
  • 3Takeshima T, Chamoto K,Wakita D, et al. Local radiationtherapy inhibits tumor growth through the generation oftumor - specific CTL: its potentiation by combination withThl cell therapy [J]. Cancer Res, 2010, 70 ( 7 ) : 2697 -2706. 被引量:1
  • 4Clark WR,Walsh CM, Glass AA,et al, Ahmed R. Molecularpathways of CTL - mediated cytotoxicityf J ]. Immunol Rev,1995,146(1) :33 -44. 被引量:1
  • 5Rosenberg SA, Yang JC, Restifo NP. Cancer immunothera-py :moving beyond current vaccines[ J] . Nat Med,2004,10(9):909 -915. 被引量:1
  • 6Ostrand - Rosenberg S. CD4 + T lymphocytes : a critical com-ponent of antitumor immunity [ J] . Cancer Invest,2005,23(5):413 -419. 被引量:1
  • 7Hombach A, Kohler H,Rappl G, et al. Human CD4 + T cellslyse target cells via granzyme/perforin upon circumventionof MHC class II restriction by an antibody - like immunore-ceptor[J].J Immunol,2006,177(8) :5668 -5675. 被引量:1
  • 8Schattner EJ,Masoarenhas J,Bishop J,et al. CD4+ T - cellinduction of Fas - mediated apoptosis in Burkitt,s lympho-ma B cellsfj]. Blood,1996,88(4) : 1375 -1382. 被引量:1
  • 9Rocha B,Tanehot C. CD8 T cell memory[ J] . Semin Immu-nol ,2004,16(5 ) :305 -314. 被引量:1
  • 10Hock H, Dorsch M, Diamantstein T,et al. Interleukin 7 in-duces CD4 + T cell - dependent tumor rejection[ J]. J ExpMed,1991,174(6) :1291 -1298. 被引量:1

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部